º»¹® ¹Ù·Î°¡±â

·Î±×ÀÎ ¹Ù·Î°¡±â


  • 2026 °øÃ¤

Á¦¾à»ê¾÷Àü·«¿¬±¸¿ø ±â¾÷Á¤º¸

Á¦¾à»ê¾÷Àü·«¿¬±¸¿ø

°ü½É±â¾÷ Ãß°¡Çϰí ä¿ë¼Ò½Ä ¹Þ±â

  • Á¦¾à»ê¾÷ °ü·Ã °³¹ß ¹× ÄÁ¼³ÆÃ¾÷
    ½Å¾à ¿¬±¸°³¹ß
    Çмú¿¬±¸¿ë¿ª »ê¾÷
    ±³À°, È«º¸¾÷
    ÀǾàǰ, ¹ÙÀÌ¿ÀÀǾàǰ, ÀǾà¿Üǰ, ÀÇ·á¿ëǰ, ÀÇ·á±â±â ¹× ±âŸ °ü·Ã Á¦Ç°ÀÇ °³¹ß, Á¦Á¶ ¹× ÆÇ¸Å
    ÀüÀÓ»ó ¹× ÀÓ»ó½ÃÇè ´ëÇà¾÷
    »êÇп¬°ü Çù·Â»ç¾÷
    ±â¾÷ °æ¿µÀü·« ¹× Á¦ÈÞ»ç¾÷ °èȹ ´ëÇà, ÀÚ¹®¾÷
    ½Äǰ(°Ç°­½Äǰ Æ÷ÇÔ) Á¦Á¶ ¹× µµ¼Ò¸Å¾÷
    ÀÇ·á±â±â, ¹Ì¿ë, Çコ±â±¸ Á¦Á¶ ¹× µµ¼Ò¸Å¾÷
    È­Àåǰ, ¼¼Á¦·ù, ÀâÈ­ Á¦Á¶ ¹× µµ¼Ò¸Å¾÷
    ÀǷẴ¿ø ¼³¸³ ¹× ¿î¿µ»ç¾÷
    ÇÐȸ, ±â¾÷¿î¿µ ¹× ¾÷¹«´ëÇà¾÷
    ÇコÄÉ¾î ¹× °Ç°­ ¼­ºñ½º¾÷
    °Ç°­ °ü·Ã¾÷(°Ç°­ º¸Á¶½Äǰ, °Ç°­°ËÁø)
    ½ÅǰÁ» Á¾ÀÚ °³¹ß(Àܵð, È­ÈÑÆ÷ÇÔ)
    ÀÛ¹°º¸È£Á¦(³ó¾à, Á¦ÃÊÁ¦, »ìÃæÁ¦ µî)
    ½Ä¹°¿¡¼­ ºÐÀÚ³ó¾÷±â¹ýÀ» ÀÌ¿ëÇÑ ÀÇÇÐÀûÀ¸·Î À¯¿ëÇÑ ´Ü¹éÁú, ¹é½Å, Ç×ü, »ê¾÷ È¿¼Ò, ¼¼Æ÷¹è¾ç¿ë ¹èÁö µîÀÇ ÀçÁ¶ÇÕ ´Ü¹éÁú »ý»ê
    ÀÇ·áÇмú°ü·Ã Á¦¹Ý»ç¾÷
    ÀÇ·á±â°ü¿î¿µ ¹× ÄÁ¼³ÆÃ¾÷
    ÃâÆÇ, ±¤°í¹°, Á¤±â°£Ç๰ Á¦ÀÛ¹ßÇà ¹× ÆÇ¸Å¾÷
    Çб³ »ç¾÷ ¹× ¹ýÀÎ »ç¾÷
    ¼ÒÇÁÆ®¿þ¾î °³¹ß ¹× µµ¼Ò¸Å¾÷
    Á¤º¸Åë½Å ¼­ºñ½º ¹× ÀÎÅÍ³Ý °ü·Ã »ç¾÷
    ÀÎÅÍ³Ý »ç¾÷ ¹× Åë½ÅÆÇ¸Å¾÷
    ÇÁ·£Â÷ÀÌÁî ¹× ´ë¸®Á¡ »ç¾÷
    »ýȰ¿ëǰ Á¦Á¶ ¹× µµ¼Ò¸Å¾÷
    ħ±¸·ù Á¦Á¶ ¹× µµ¼Ò¸Å¾÷
    ¿å½Ç ¹× ÁÖ¹æ¿ëǰ Á¦Á¶ ¹× µµ¼Ò¸Å¾÷
    ³ó»ê¹°ÀÇ À¯Åë, °¡°ø, ÆÇ¸Å
    ³óÀÛ¾÷ÀÇ ÀüºÎ ¶Ç´Â ÀϺΠ´ëÇà
    ¿µ³ó¿¡ ÇÊ¿äÇÑ ÀÚÀçÀÇ »ý»ê, °ø±Þ
    ¿µ³ó¿¡ ÇÊ¿äÇÑ Á¾¹¦»ý»ê ¹× Á¾±Õ¹è¾ç»ç¾÷
    ³ó»ê¹°ÀÇ ¸ÅÃë, ºñÃà»ç¾÷
    ³ó¾÷±â°è, ±âŸÀåºñÀÇ ÀÓ´ë, ¼ö¸®, º¸°ü»ç¾÷
    ¼Ò±Ô¸ð °ü°³½Ã¼³ÀÇ ¼öŹ, °ü¸®»ç¾÷
    µ¿¹°ÀǾàǰ Á¦Á¶ ¹× µµ¼Ò¸Å
    À§ °¢È£¿¡ °ü·ÃµÈ ¼öÃâÀÔ¾÷
    À§ °¢È£¿¡ °ü·ÃµÈ ºÎ´ë»ç¾÷ ÀÏü
  • ±â¾÷¸íÁ¦¾à»ê¾÷Àü·«¿¬±¸¿ø
  • ±â¾÷±Ô¸ðÁß¼Ò±â¾÷
  • ´ëÇ¥ÀÚÁ¤À±ÅÃ
  • ¼³¸³ÀÏ2016³â 8¿ù 22ÀÏ
  • ¸ÅÃâ¾× 4¾ï 1,000¸¸¿ø (2021)
  • »ç¿ø¼ö 9 ¸í ÀçÁ÷Áß
  • Æò±Õ¿¬ºÀ4,139¸¸¿ø
  • ÀÚº»±Ý 1¾ï¿ø

ȸ»ç¼Ò°³

  • ȸ»ç¼Ò°³


  • Á¦¾à»ê¾÷Àü·«¿¬±¸¿ø(PSI)Àº

    Á¦¾à»ê¾÷ÀÇ °¡Ä¡»ç½½ Àü Áֱ⿡ °ÉÄ£ ¼­ºñ½º¸¦ Á¦°øÇÏ´Â PDO(Pharmaceutical Development Organization)
    ·Î¼­ Àü¹®¼º°ú ½Å·Ú¸¦ ¹ÙÅÁÀ¸·Î Á¦¾à¹ÙÀÌ¿À»ê¾÷ÀÇ Çõ½ÅÀûÀ̰í Áö¼Ó°¡´ÉÇÑ ºñÁî´Ï½º ¸ðµ¨À» ¹ß±¼ÇÏ¿©
    ¿ì¸® Á¦¾à¹ÙÀÌ¿À»ê¾÷ÀÇ ±Û·Î¹úÁøÃâ ¹× ½Å¾à°³¹ß¿ª·® °­È­¸¦ Áö¿øÇÏ´Â ¿¬±¸¡¤ÄÁ¼³ÆÃ ±â°üÀÔ´Ï´Ù.

  • Pharmaceutical Strategy Institute (PSI) is

    a research and consulting institute as a pharmaceutical development organization(PDO). We suggest solution
    for all value chain of pharmaceutical industry that supports the advancement of pharmaceutical bio industry
    into the global market and enhancement of new drug development capabilities by exploring innovative and sustainable
    business models based on expertise and trust.

ȸ»ç¼Ò°³ ±âº» À̹ÌÁö
  • ÀÎÀç»ó
  • Mission

    Discovering and Supporting Sustainable Business Model for Creating Core Value New Drug Developing
    Á¦¾à»ê¾÷ÀÇ ±Û·Î¹úÈ­¡¤½Å¾à°³¹ß ¿ª·® Áö¿øÀ» À§ÇÑ Àü¹®¿¬±¸±â°ü

  • Vision

    Discovering and Supporting Sustainable Business Model for Creating Core Value
    ÇÙ½É °¡Ä¡ âÃâÀ» À§ÇÑ ±â¾÷ÀÇ Áö¼Ó °¡´ÉÇÑ ºñÁî´Ï½º¸ðµ¨ ¹ß±¼ ¹× Áö¿ø

Core Value

À̹ÌÁö
  • ¿¬Çõ
  • 2022.04»ç¾÷Àå ÀÌÀü(¼­¿ï½Ã ¿µµîÆ÷±¸ ¿©Àǵµµ¿ ÄÞºñºôµù)
  • 2022.02¿¬±¸°³¹ß¼­ºñ½º¾÷½Å°í(°úÇбâ¼úÁ¤º¸Åë½ÅºÎ)
  • 2021.01¼öÃâÁö¿ø±â¹ÝȰ¿ë»ç¾÷ ¼öÇà±â°ü ¼±Á¤(2021.01~2022.12) (KOTRA, Áß¼Ò±â¾÷ÁøÈï°ø´Ü)
  • 2020.11Çõ½ÅÁ¤Ã¥¿¬±¸¼¾ÅÍ(InnoPol) Á¤Ã¥»ç¹«±¹ ÁöÁ¤ (Çѱ¹½Å¾à°³¹ß¿¬±¸Á¶ÇÕ)
  • 2020.03¼­¿ï¹ÙÀÌ¿ÀÇãºê Çù·Â±â°ü ¼±Á¤(2020.04~2021.03)
  • 2020.02±â¾÷ºÎ¼³¿¬±¸¼Ò ÀÎÁ¤(°ú±âÁ¤ÅëºÎ)
  • 2019.12»ç¾÷Àå ÀÌÀü (¼­¿ï½Ã ¿µµîÆ÷±¸ ¿©Àǵµµ¿ ¶óÀÌÇÁ ¿ÀÇǽºÅÚ)
  • 2019.10Bio Mansfield Incubator, Tech Black Hole 3ÀÚ MOU ü°á
  • 2019.04¼­¿ï¹ÙÀÌ¿ÀÇãºê Çù·Â±â°ü ¼±Á¤(2019.04~2020.03)
  • 2019.02Çѱ¹½Å¾à°³¹ß¿¬±¸Á¶ÇÕ ÀÌ»çÀå °ø·ÎÆÐ ¼ö»ó
  • 2018.122018³â ±¹È¸ °úÇбâ¼úÁ¤º¸Åë½ÅÀ§¿øÀå ¼ö»ó
  • 2018.09´ëÇѹα¹À» À̲ô´Â Çõ½Å ¸®´õ Á¦¾à»ê¾÷ºÎ¹® ´ë»ó(´º½º¸ÞÀÌÄ¿)
  • 2017.02¿¡Äâµµ¸£ ÄÁ¼³ÆÃ ÆÄÆ®³Ê Genial MOU ü°á
  • 2016.09Á¦¾à»ê¾÷Àü·«¿¬±¸¿ø(PSI) ƯÇãû »óÇ¥µî·Ï
  • 2016.09À¯·´ ÄÁ¼³ÆÃ ÆÄÆ®³Ê Woodley Bioreg MOU ü°á
  • 2016.09µ¥ÀÌÅ͸ð´ÏÅÍ Çѱ¹Áö»ç ÆÄÆ®³Ê Çñ½º MOU ü°á
  • 2016.09GMP ÄÁ¼³ÆÃ ÆÄÆ®³Ê ½´¾î¾î½Ã½ºÆ® MOU ü°á
  • 2016.09°øÀÎȸ°è ÄÁ¼³ÆÃ ÆÄÆ®³Ê ¿µ¾ØÀ¯È¸°è¹ýÀÎ MOU ü°á
  • 2016.08Á¦¾à»ê¾÷Àü·«¿¬±¸¿ø(PSI) ¼³¸³

º¹¸®ÈÄ»ý

  • ÈÞ¹«/±â³äÀÏÁÖ5Àϱٹ«,¿¬Â÷
  • 4´ëº¸Çè±¹¹Î¿¬±Ý,ÀǷẸÇè,»êÀ纸Çè,°í¿ëº¸Çè
  • º¸Àå/º¸»óÀμ¾Æ¼ºê,Àå±â±Ù¼ÓÆ÷»ó,ÅðÁ÷¿¬±Ý
  • ±Ù¹«È¯°æ/ÆíÀÇÁ¡½É½Ä»çÁ¦°ø,°£½ÄÁ¦°ø

    ±â¾÷À§Ä¡

    • ÁÖ¼Ò : ¼­¿ïƯº°½Ã ¿µµîÆ÷±¸ 63·Î 32 822È£ (¿©Àǵµµ¿,ÄÞºñºôµù)
    • ȨÆäÀÌÁö : http://www.psi.re.kr

    µ¿ÀÏ ±â¾÷ÀÌ¶óµµ Å¸Áö¿ª ä¿ëÀÇ °æ¿ì, ȸ»ç ÁÖ¼Ò¿Í Àα٠ÁöÇÏö Á¤º¸°¡ »óÀÌÇÒ ¼ö ÀÖ½À´Ï´Ù.